Specific Egg Yolk Immunoglobulin as a New Preventive Approach for Shiga-Toxin-Mediated Diseases

• Paola Neri,

  Affiliation Microbiology, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, Japan

  ⨯
• Shunji Tokoro,

  Affiliation Microbiology, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, Japan

  ⨯
• Ryo Kobayashi,

  Affiliation Microbiology, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, Japan

  ⨯
• Tsuyoshi Sugiyama,

  Affiliation Microbiology, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, Japan

  ⨯
• Kouji Umeda,

  Current address: Immunology Research Institute, EW Nutrition Japan K.K., Gifu, Japan

  Affiliation Immunology Research Institute, GHEN Corporation, Gifu, Japan

  ⨯
• Takeshi Shimizu,

  Affiliation Department of Molecular Infectiology, Graduate School of Medicine, Chiba University, Chiba, Japan

  ⨯
• Takao Tsuji,

  Affiliation Department of Microbiology, School of Medicine, Fujita Health University, Aichi, Japan

  ⨯
• Yoshikatsu Kodama,

  Current address: Immunology Research Institute, EW Nutrition Japan K.K., Gifu, Japan

  Affiliation Immunology Research Institute, GHEN Corporation, Gifu, Japan

  ⨯
• Keiji Oguma,

  Affiliation Department of Bacteriology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

  ⨯
• Hiroshi Mori

  * E-mail: morih@gifu-pu.ac.jp

  Affiliation Microbiology, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, Gifu, Japan

  ⨯